Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bhim Sen Singhal"'
Publikováno v:
Annals of Indian Academy of Neurology, Vol 17, Iss 1, Pp 77-81 (2014)
Background: There is insufficient data on the clinical and radiological features of neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorders (NMOSD) from India. Objective: The objective of the following study is to examine the clinico-r
Externí odkaz:
https://doaj.org/article/71dea20d781e445d9f3208beae8a943c
Autor:
Bhim Sen Singhal, Sarosh M Katrak
Publikováno v:
Annals of Indian Academy of Neurology, Vol 19, Iss 2, Pp 292-293 (2016)
Externí odkaz:
https://doaj.org/article/06ea6e969bbb4f819a870078b2624700
Autor:
Jaydip Ray Chaudhuri, Jui Jade Bagul, Alluri Swathi, Bhim Sen Singhal, N. Chakradhar Reddy, Kiran Kumar Vallam
Publikováno v:
Neurology(R) neuroimmunologyneuroinflammation. 9(6)
The production of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) can cause a spectrum of autoimmune disorders, including optic neuritis, transverse myelitis, brainstem encephalitis, and acute disseminated encephalomyelitis. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d301807317de8629ea6d957795d6911c
https://pubmed.ncbi.nlm.nih.gov/36261298
https://pubmed.ncbi.nlm.nih.gov/36261298
Autor:
Thomas Mathew, Vikram Kamath, Saji K John, M Netravathi, Rajesh B Iyer, S Raghavendra, Suresh Kumar, M.L. Neeharika, Salil Gupta, Uday Murgod, R. Shivakumar, Ravi K Annadure, Nasli Ichaporia, Anshu Rohatgi, Sruthi S Nair, Sireesha Yareeda, Bawani Anand, Prabhjeet Singh, Umashankar Renukaradhya, V. Arulselvan, Y Muralidhar Reddy, Nirmal Surya, G.R.K. Sarma, Raghunandan Nadig, Saikanth Deepalam, G.G. Sharath Kumar, P. Satishchandra, Bhim Sen Singhal, Gareth Parry
Publikováno v:
Multiple Sclerosis and Related Disorders. 66:104059
Natalizumab (NTZ) is increasingly being used in Indian multiple sclerosis (MS) patients. There are no reports on its safety and efficacy, especially with respect to the occurrence of progressive multifocal leukoencephalopathy (PML).To describe the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d6a1bc2df9e807e9fc377134f51c26
https://doi.org/10.1016/j.msard.2022.104059
https://doi.org/10.1016/j.msard.2022.104059